Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

HSP 90 inhibitors show potent activity in preclinical models of CRPC

June 11, 2010

Nektar Therapeutics reports phase II data on NKTR-102 in breast cancer

June 10, 2010

QBI-139 enters phase I trial in advanced/refractory solid tumors

June 10, 2010

Simvastatin/ezetimibe combination promotes tumor growth in prostate cancer model

June 10, 2010

Potent inhibitors identified of GIST-relevant kinases

June 10, 2010

PTC receives award to develop anticancer drugs targeting BMI-1

June 9, 2010

Antitumor agent MSC-1936369B shows safety in phase I trial

June 9, 2010

Irinotecan/S-1 active in 5-FU-resistant bladder cancer cell lines

June 9, 2010

Phase III trial of plitidepsin initiated in multiple myeloma

June 8, 2010

TK therapy R&D project receives grant from Regione Lombardia

June 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...